FindTrial
Sign In

Hysteroscopic or uterus cervical sentinel lymph node mapping of endometrial cancer

Hysteroscopic or uterus cervical sentinel lymph node mapping of endometrial cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015603
Enrollment
Unknown
Registered
2018-04-11
Start date
2018-04-16
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrium cancer

Interventions

Gold Standard:histological pathology
Index test:SLN mapping

Sponsors

Department of Gynecologic oncology, Beijing Obstetrics and Gynecology Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 69 Years

Inclusion criteria

Inclusion criteria: preoperative stage I endometrial carcinoma

Exclusion criteria

Exclusion criteria: 1. Severe than stage I endometrium cancer; 2. special patholoyg types; 3. pelvic radiotherapy history; 4. unendurable surgery.

Design outcomes

Primary

MeasureTime frame
sentinel lymph node;lymph node pathology analysis;—

Countries

China

Contacts

Public ContactJin Weimiao

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

miaojinweigyn@163.com+86 18518705638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026